Global Lipid Nanoparticles (LNP) Market Growth (Status and Outlook) 2023-2029

Global Lipid Nanoparticles (LNP) Market Growth (Status and Outlook) 2023-2029

LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.
LPI (LP Information)' newest research report, the “Lipid Nanoparticles (LNP) Industry Forecast” looks at past sales and reviews total world Lipid Nanoparticles (LNP) sales in 2022, providing a comprehensive analysis by region and market sector of projected Lipid Nanoparticles (LNP) sales for 2023 through 2029. With Lipid Nanoparticles (LNP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Nanoparticles (LNP) industry.
This Insight Report provides a comprehensive analysis of the global Lipid Nanoparticles (LNP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lipid Nanoparticles (LNP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Nanoparticles (LNP) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Nanoparticles (LNP) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Nanoparticles (LNP).
The global Lipid Nanoparticles (LNP) market size is projected to grow from US$ 570.5 million in 2022 to US$ 951 million in 2029; it is expected to grow at a CAGR of 7.6% from 2023 to 2029.
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Nanoparticles (LNP) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others
Segmentation by application
Vaccines and Drugs
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid

Please note: The report will take approximately 2 business days to prepare and deliver.